BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 34063385)

  • 21. Inter-laboratory comparison of 2 ELISA kits used for foot-and-mouth disease virus nonstructural protein serology.
    Browning CFJ; Di Nardo A; Henry L; Pollard T; Hendry L; Romey A; Relmy A; Eble P; Brocchi E; Grazioli S; King DP; Ludi AB
    J Vet Diagn Invest; 2020 Nov; 32(6):933-937. PubMed ID: 33025858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of an r3AB1-FMDV-NSP ELISA to distinguish between cattle infected and vaccinated with foot-and-mouth disease virus.
    Jaworski JP; Compaired D; Trotta M; Perez M; Trono K; Fondevila N
    J Virol Methods; 2011 Dec; 178(1-2):191-200. PubMed ID: 21946290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in diagnostic techniques for differentiating infection from vaccination in foot-and-mouth disease.
    Clavijo A; Wright P; Kitching P
    Vet J; 2004 Jan; 167(1):9-22. PubMed ID: 14623146
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and validation of a prokaryotically expressed foot-and-mouth disease virus non-structural protein 2C'3AB-based immunochromatographic strip to differentiate between infected and vaccinated animals.
    Wu L; Jiang T; Lu ZJ; Yang YM; Sun P; Liang Z; Li D; Fu YF; Cao YM; Liu XT; Liu ZX
    Virol J; 2011 Apr; 8():186. PubMed ID: 21513550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cedivac-FMD can be used according to a marker vaccine principle.
    Chénard G; Selman P; Dekker A
    Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of an indirect enzyme-linked immunosorbent assay for detection of foot-and-mouth disease virus nonstructural protein antibody using a chemically synthesized 2B peptide as antigen.
    Inoue T; Parida S; Paton DJ; Linchongsubongkoch W; Mackay D; Oh Y; Aunpomma D; Gubbins S; Saeki T
    J Vet Diagn Invest; 2006 Nov; 18(6):545-52. PubMed ID: 17121081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of three commercial ELISA kits for detection of antibodies to a nonstructural protein of foot-and-mouth disease virus.
    Fukai K; Morioka K; Onozato H; Yoshida K; Sakamoto K
    J Vet Med Sci; 2013; 75(6):693-9. PubMed ID: 23328606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-structural protein 3A for differentiation of foot-and-mouth disease infected and vaccinated animals in Haryana (India).
    Kumar N; Sharma R; Kakker NK
    Zoonoses Public Health; 2007; 54(9-10):376-82. PubMed ID: 18035976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Within herd transmission and evaluation of the performance of clinical and serological diagnosis of foot-and-mouth disease in partially immune cattle herds.
    Gonzales JL; Barrientos MA; Quiroga JL; Ardaya D; Daza O; Martinez C; Orozco C; Crowther J; Paton DJ
    Vaccine; 2014 Oct; 32(47):6193-8. PubMed ID: 25261377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiating infection from vaccination in foot-and-mouth-disease: evaluation of an ELISA based on recombinant 3ABC.
    Bruderer U; Swam H; Haas B; Visser N; Brocchi E; Grazioli S; Esterhuysen JJ; Vosloo W; Forsyth M; Aggarwal N; Cox S; Armstrong R; Anderson J
    Vet Microbiol; 2004 Jul; 101(3):187-97. PubMed ID: 15223123
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Truncated recombinant non-structural protein 2C-based indirect ELISA for FMD sero-surveillance.
    Mahajan S; Mohapatra JK; Pandey LK; Sharma GK; Pattnaik B
    J Virol Methods; 2013 Nov; 193(2):405-14. PubMed ID: 23850716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Review of OIE Country Status Recovery Using Vaccinate-to-Live Versus Vaccinate-to-Die Foot-and-Mouth Disease Response Policies I: Benefits of Higher Potency Vaccines and Associated NSP DIVA Test Systems in Post-Outbreak Surveillance.
    Barnett PV; Geale DW; Clarke G; Davis J; Kasari TR
    Transbound Emerg Dis; 2015 Aug; 62(4):367-87. PubMed ID: 24112127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a Luminex assay for the detection of swine antibodies to non-structural proteins of foot-and-mouth disease virus.
    Chen TH; Lee F; Lin YL; Pan CH; Shih CN; Lee MC; Tsai HJ
    J Immunol Methods; 2013 Oct; 396(1-2):87-95. PubMed ID: 23962586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a chemiluminescence immunoassay using recombinant non-structural epitope-based proteins to accurately differentiate foot-and-mouth disease virus-infected and vaccinated bovines.
    Liu ZZ; Zhao FR; Gao SD; Shao JJ; Zhang YG; Chang HY
    Transbound Emerg Dis; 2018 Apr; 65(2):338-344. PubMed ID: 29341485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of laboratory tests for SAT serotypes of foot-and-mouth disease virus with specimens collected from convalescent cattle in Zimbabwe.
    Sammin DJ; Paton DJ; Parida S; Ferris NP; Hutchings GH; Reid SM; Shaw AE; Holmes C; Gibson D; Corteyn M; Knowles NJ; Valarcher JF; Hamblin PA; Fleming L; Gwaze G; Sumption KJ
    Vet Rec; 2007 May; 160(19):647-54. PubMed ID: 17496271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An ELISA based on the repeated foot-and-mouth disease virus 3B epitope peptide can distinguish infected and vaccinated cattle.
    Gao M; Zhang R; Li M; Li S; Cao Y; Ma B; Wang J
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1271-9. PubMed ID: 22207215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foot-and-Mouth Disease in Red Deer - Experimental Infection and Test Methods Performance.
    Kittelberger R; Nfon C; Swekla K; Zhang Z; Hole K; Bittner H; Salo T; Goolia M; Embury-Hyatt C; Bueno R; Hannah M; Swainsbury R; O'Sullivan C; Spence R; Clough R; McFadden A; Rawdon T; Alexandersen S
    Transbound Emerg Dis; 2017 Feb; 64(1):213-225. PubMed ID: 25907028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of two 3ABC enzyme-linked immunosorbent assays for diagnosis of multiple-serotype foot-and-mouth disease in a cattle population in an area of endemicity.
    Bronsvoort BM; Sørensen KJ; Anderson J; Corteyn A; Tanya VN; Kitching RP; Morgan KL
    J Clin Microbiol; 2004 May; 42(5):2108-14. PubMed ID: 15131177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antibodies specific for foot-and-mouth disease virus infection using indirect ELISA based on recombinant nonstructural protein 2B.
    Biswal JK; Jena S; Mohapatra JK; Bisht P; Pattnaik B
    Arch Virol; 2014 Jul; 159(7):1641-50. PubMed ID: 24420160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic potential of Mab-based ELISAs for antibodies to non-structural proteins of foot-and-mouth disease virus to differentiate infection from vaccination.
    Brocchi E; De Diego MI; Berlinzani A; Gamba D; De Simone F
    Vet Q; 1998; 20 Suppl 2():S20-4. PubMed ID: 9652058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.